Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Asset Writedowns and Impairment (2020 - 2024)

Historic Asset Writedowns and Impairment for Quipt Home Medical (QIPT) over the last 5 years, with Q2 2024 value amounting to $3.2 million.

  • Quipt Home Medical's Asset Writedowns and Impairment rose 3228.87% to $3.2 million in Q2 2024 from the same period last year, while for Jun 2024 it was $11.6 million, marking a year-over-year increase of 1098.54%. This contributed to the annual value of $10.1 million for FY2023, which is 1766.87% down from last year.
  • Per Quipt Home Medical's latest filing, its Asset Writedowns and Impairment stood at $3.2 million for Q2 2024, which was up 3228.87% from $2.7 million recorded in Q1 2024.
  • In the past 5 years, Quipt Home Medical's Asset Writedowns and Impairment registered a high of $3.4 million during Q2 2022, and its lowest value of $1.6 million during Q2 2020.
  • In the last 5 years, Quipt Home Medical's Asset Writedowns and Impairment had a median value of $2.5 million in 2023 and averaged $2.5 million.
  • As far as peak fluctuations go, Quipt Home Medical's Asset Writedowns and Impairment soared by 10237.81% in 2022, and later crashed by 2876.03% in 2023.
  • Over the past 5 years, Quipt Home Medical's Asset Writedowns and Impairment (Quarter) stood at $2.1 million in 2020, then increased by 16.02% to $2.4 million in 2021, then fell by 5.35% to $2.3 million in 2022, then rose by 22.21% to $2.8 million in 2023, then grew by 14.98% to $3.2 million in 2024.
  • Its last three reported values are $3.2 million in Q2 2024, $2.7 million for Q1 2024, and $2.8 million during Q4 2023.